Semaglutide Beneficial in HFpEF Patients With Diabetes : com

In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.

Related Keywords

Missouri , United States , Toronto , Ontario , Canada , Mikhailn Kosiborod , Bethl Abramson , , Clinical Research , American College Of Cardiology , University Of Toronto , Luke Health System , Health System , Kansas City , Study Entry , Featured Clinical Research , American College , New England Journal , Are Significantly Lower , Heart Failure , Obesity , Bese , Weight Loss , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , T2dm , 2d , Weight Management , Quality Of Life , Pol , Ealth Related Quality Of Life , Rqol , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors ,